The impact of acetylation and deacetylation on the p53 pathway
- 1.6k Downloads
The p53 tumor suppressor is a sequence-specific transcription factor that undergoes an abundance of post-translational modifications for its regulation and activation. Acetylation of p53 is an important reversible enzymatic process that occurs in response to DNA damage and genotoxic stress and is indispensible for p53 transcriptional activity. p53 was the first non-histone protein shown to be acetylated by histone acetyl transferases, and a number of more recent in vivo models have underscored the importance of this type of modification for p53 activity. Here, we review the current knowledge and recent findings of p53 acetylation and deacetylation and discuss the implications of these processes for the p53 pathway.
Keywordsp53 Mdm2 acetylation deacetylation destabilization ubiquitination transcriptional activation and stability
- Goodman, R.H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14, 1553–1577.Google Scholar
- Itahana, K., Mao, H., Jin, A., Itahana, Y., Clegg, H.V., Lindström, M.S., Bhat, K.P., Godfrey, V.L., Evan, G.I., and Zhang, Y. (2007). Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12, 355–366.CrossRefGoogle Scholar
- Knights, C.D., Catania, J., Di Giovanni, S., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A.A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006). Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173, 533–544.CrossRefGoogle Scholar